keyword
https://read.qxmd.com/read/38152320/ongoing-challenges-of-off-label-prescribing
#21
REVIEW
Richard O Day
Off-label prescribing refers to prescribing that is not concordant with the indications, doses, routes of administration or patient groups included in the Australian approved product information. Off-label prescribing is common, especially for vulnerable patient groups who tend to be excluded from clinical trials, such as children and pregnant women. There may be increased risk of prescriber liability if the patient experiences an adverse event following off-label prescription, particularly when supporting evidence or guidelines are lacking...
December 2023: Australian Prescriber
https://read.qxmd.com/read/38143365/quetiapine-oral-solution-in-alzheimer-s-disease-efficacy-and-dosage-insights-from-a-real-world-retrospective-study
#22
JOURNAL ARTICLE
Kuan-Ying Li, Bin-Tse Lin, Shu-Ting Hsu, Ching-Fang Chien, Yang-Pei Chang, Yuan-Han Yang
BACKGROUND: Neuropsychiatric symptoms (NPS) are distressing for patients with dementia, often accelerating functional decline and nursing home placement. Medications such as quetiapine are used to alleviate NPS, but their side effects require cautious use. Liquid formulations such as quetiapine oral suspension suit specific populations; however, real-world data on their use in patients with dementia are limited. OBJECTIVE: The purpose of this retrospective, naturalistic study was to provide preliminary data on the effects of treatment with quetiapine oral suspension on behavioral and psychiatric disturbances in Alzheimer's disease (AD) outpatients in Taiwan...
December 20, 2023: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38124305/analysis-of-atypical-antipsychotics-induced-adverse-events-related-to-diabetes-mellitus-in-patients-with-dementia-using-the-japanese-adverse-drug-event-report-database
#23
JOURNAL ARTICLE
Fuga Habuchi, Natsuko Ishida, Ryo Matsushita, Junko Ishizaki, Yukio Suga
BACKGROUND: Patients with dementia are prescribed low-dose atypical antipsychotics (AAPs) to treat psycho-behavioral symptoms. Although AAPs are known to cause diabetes mellitus-related adverse events (DMAEs), information regarding AAPs-induced DMAEs experienced by patients with dementia is lacking. OBJECTIVE: To use the Japan Adverse Drug Event Report (JADER) database to assess the onset tendencies and patterns of DMAEs attributable to AAPs prescribed to patients with dementia...
November 24, 2023: Annals of Pharmacotherapy
https://read.qxmd.com/read/38108086/insights-into-the-population-pharmacokinetics-and-pharmacodynamics-of-quetiapine-a-systematic-review
#24
REVIEW
Lu Han, Jia-Qin Gu, Jue-Hui Mao, Xiao-Qin Liu, Zheng Jiao
INTRODUCTION: Quetiapine exhibits notable pharmacokinetic and pharmacodynamic (PK/PD) variability, the origins of which are poorly understood. This systematic review summarizes published population PK/PD studies and identifies significant covariates accounting for this variability to inform precision dosing. METHODS: We systematically searched the PubMed, Web of Science, and Embase databases and compared study characteristics, model parameters, and covariate effects...
December 18, 2023: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38088718/use-of-psychotropic-drugs-during-the-covid-19-pandemic-in-minas-gerais-brazil
#25
JOURNAL ARTICLE
Juliana Cerqueira Barros, Sarah Nascimento Silva
OBJECTIVE: To describe the profile of dispensation of mental health drugs by analyzing trends in use before and during the COVID-19 pandemic within the Unified Health System (Sistema Único de Saúde [SUS]). METHODS: Pharmacoepidemiological study based on the retrospective analysis of records regarding the dispensation of psychotropic medicines in the SUS database in the state of Minas Gerais between 2018 and 2021, considering the periods before (2018-2019) and during the COVID-19 pandemic (2020-2021)...
2023: Brazilian Journal of Epidemiology
https://read.qxmd.com/read/38077716/successful-management-of-severe-bupropion-toxicity-with-lipid-emulsion-therapy-a-complex-case-report-and-literature-review
#26
JOURNAL ARTICLE
Fahad Eid, Andrew Takla, Mohamed Magdi Eid, Mostafa Najim, Mostafa Reda Mostafa
UNLABELLED: This case report presents the management of a 53-year-old female with a complex psychiatric history who ingested multiple medications, resulting in severe cardiovascular compromise and subsequent respiratory failure. The patient's ingestion included clonidine, fluoxetine, gabapentin, quetiapine and bupropion. Initial treatment involved supportive measures, including fluid resuscitation, bicarbonate infusion and correction of electrolyte imbalances. Despite these interventions, the patient remained haemodynamically unstable, requiring multiple vasopressors...
2023: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/38074415/inappropriate-quetiapine-use-at-a-large-academic-medical-center-frequency-of-misuse-and-associated-costs-of-adverse-effects
#27
JOURNAL ARTICLE
Winter Roth, David Dadiomov, Michelle Chu
BACKGROUND: Quetiapine is an antipsychotic with dose-related receptor affinity, which is commonly prescribed by specialties outside of psychiatry. Quetiapine can have adverse effects including weight gain, hyperglycemia, and falls. Therefore, quetiapine is a good focus medication to assess the need for an antipsychotic stewardship protocol. OBJECTIVE: To assess the need for an antipsychotic stewardship protocol at a large, urban academic medical center by evaluating quetiapine usage...
2023: Therapeutic Advances in Drug Safety
https://read.qxmd.com/read/38054081/roles-of-fatty-acid-chain-length-and-enzyme-oriented-drug-controlled-release-from-ph-triggering-self-assembled-fatty-acid-conjugated-quetiapine-nanosuspensions
#28
JOURNAL ARTICLE
Hy D Nguyen, Hai V Ngo, Van Hong Nguyen, Myung-Chul Gil, Beom-Jin Lee
BACKGROUND: Quetiapine (QTP) is a first-line antipsychotic drug, but its therapeutic druggability and patient adherence were limited due to high oral dose strength, low bioavailability and physicochemical/biopharmaceutical issues. PURPOSE: To investigate the roles of fatty acid chain length and enzyme-oriented QTP controlled release from pH-triggering self-assembled fatty acid conjugated QTP nanosuspensions (NSPs). METHODS: QTP was conjugated with different chain length fatty acids (C10-decanoic acid, C14-myristic acid, C18-stearic acid) to obtain QTP-fatty acid conjugates (QFCs: QD, QM, QS) by exploiting 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/4-dimethylaminopyridine (EDC/DMAP) conjugation chemistry...
2023: International Journal of Nanomedicine
https://read.qxmd.com/read/38033746/prescribing-pattern-of-antipsychotics-for-patients-with-schizophrenia-using-the-total-daily-dose-online-tool
#29
JOURNAL ARTICLE
Jawza F Alsabhan, Haya M Almalag, Lubna Aljafali, Hessa Alnughamish, Gaida Almutlaq
This study aimed to investigate the prescribing pattern of antipsychotic medications for schizophrenia using the British National Formulary total daily dose (TDD) online tool. We analysed data from the electronic medical records at King Khalid University Hospital (KKUH) of 272 patients diagnosed with schizophrenia who were prescribed both typical and atypical antipsychotic medications. The results showed that aripiprazole was the most commonly prescribed antipsychotic drug, followed by haloperidol then risperidone...
December 2023: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38021335/veno-venous-extracorporeal-membrane-oxygenation-anesthetic-considerations-in-clinical-practice
#30
REVIEW
Kimberly L Skidmore, Alireza Rajabi, Angela Nguyen, Farnad Imani, Alan D Kaye
CONTEXT: After the COVID-19 pandemic, multiple reviews have documented the success of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Patients who experience hypoxemia but have normal contractility may be switched to veno-venous-ECMO (VV-ECMO). PURPOSE: In this review, we present three protocols for anesthesiologists. Firstly, transesophageal echocardiography (TEE) aids in cannulation and weaning off inotropes and fluids. Our main objective is to assist in patient selection for the Avalon Elite single catheter, which is inserted into the right internal jugular vein and terminates in the right atrium...
June 2023: Anesthesiology and Pain Medicine
https://read.qxmd.com/read/37999569/biodetoxification-using-intravenous-lipid-emulsion-a-rescue-therapy-in-life-threatening-quetiapine-and-venlafaxine-poisoning-a-case-report
#31
Cristian Cobilinschi, Liliana Mirea, Cosmin-Andrei Andrei, Raluca Ungureanu, Ana-Maria Cotae, Oana Avram, Sebastian Isac, Ioana Marina Grințescu, Radu Țincu
The administration of intravenous lipid emulsion (ILE) is a proven antidote used to reverse local anesthetic-related systemic toxicity. Although the capacity of ILE to generate blood tissue partitioning of lipophilic drugs has been previously demonstrated, a clear recommendation for its use as an antidote for other lipophilic drugs is still under debate. Venlafaxine (an antidepressant acting as a serotonin-norepinephrine reuptake inhibitor (SNRI)) and quetiapine (a second-generation atypical antipsychotic) are widely used in the treatment of psychotic disorders...
November 9, 2023: Toxics
https://read.qxmd.com/read/37968732/symptomatic-treatment-options-for-huntington-s-disease-guidelines-of-the-german-neurological-society
#32
JOURNAL ARTICLE
Carsten Saft, Jean-Marc Burgunder, Matthias Dose, Hans Heinrich Jung, Regina Katzenschlager, Josef Priller, Huu Phuc Nguyen, Kathrin Reetz, Ralf Reilmann, Klaus Seppi, Georg Bernhard Landwehrmeyer
INTRODUCTION: Ameliorating symptoms and signs of Huntington's disease (HD) is essential to care but can be challenging and hard to achieve. The pharmacological treatment of motor signs (e.g. chorea) may favorably or unfavorably impact other facets of the disease phenotype (such as mood and cognition). Similarly, pharmacotherapy for behavioral issues may modify the motor phenotype. Sometimes synergistic effects can be achieved. In patients undergoing pragmatic polypharmacological therapy, emerging complaints may stem from the employed medications' side effects, a possibility that needs to be considered...
November 16, 2023: Neurological research and practice
https://read.qxmd.com/read/37961072/prescription-patterns-of-quetiapine-for-multiple-drug-abuse-depression-and-psychosis-a-retrospective-study
#33
JOURNAL ARTICLE
Ayman M Al-Qaaneh, Osama S Al-Mohammadi, Razan A Musharraf, Jumanah S AlSaedi, Jana L Shaker, Ahmed J Aldhafiri
BACKGROUND: Quetiapine is an atypical antipsychotic prescribed for schizophrenia, bipolar disorder, multiple drug abuse (MDA), generalized anxiety disorder, severe depression, dementia, and mood disorders. Prescription of quetiapine varies according to use, with side effects increasingly reported with higher doses. Many previous case reports highlighted the misuse of the drug. Here we studied the prescribing patterns of quetiapine in multiple drug abuse (MDA), depression, and psychosis patients in the Madinah region in Saudi Arabia...
December 2023: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/37941354/on-and-off-label-utilisation-of-antipsychotics-in-australia-2000-2021-retrospective-analysis-of-two-medication-datasets
#34
JOURNAL ARTICLE
Ramya Padmavathy Radha Krishnan, Christopher Harrison, Nicholas Buckley, Jacques Eugene Raubenheimer
OBJECTIVE: To determine antipsychotic utilisation patterns in Australian adults from 2005 to 2021, with a focus on on-label and off-label prescriptions. METHODS: We examined antipsychotic dispensing trends in adults from 2005 to 2021 using a 10% sample of the Pharmaceutical Benefits Scheme (PBS) dataset, which contains patient-level information on medicines dispensed throughout Australia. The lack of diagnostic information in PBS was substituted by analysing BEACH (Bettering the Evaluation And Care of Health) dataset, a cross-sectional national survey from 2000 to 2016, consisting of data from general practitioner-patient encounters...
November 9, 2023: Australian and New Zealand Journal of Psychiatry
https://read.qxmd.com/read/37926567/-effects-of-preoperative-quetiapine-on-postoperative-delirium-and-sleep-quality-in-elderly-orthopaedic-patients
#35
JOURNAL ARTICLE
Y P Yang, Y Y Ding, Y Y Wang, W W Wang, K P Ye, Q G Ye, J Li
Objective: To investigate the effects of preoperative quetiapine on postoperative delirium (POD) and sleep quality in elderly orthopedic patients. Methods: Prospectively, 111 elderly patients, American Society of Anesthesiologists (ASA) grade Ⅱ-Ⅲ, scheduled to undergo knee or hip surgery in the Affiliated Huangyan Hospital of Wenzhou Medical University under continuous spinal anesthesia from August 2021 to March 2023, were selected and randomly divided into two groups by random number table: control group (group C, 1 h preoperative placebo) and quetiapine group (group Q, 1 h preoperative quetiapine 12...
November 7, 2023: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/37870577/combined-in-vivo-metabolic-effects-of-quetiapine-and-methadone-in-brain-and-blood-of-rats
#36
JOURNAL ARTICLE
Laura Smedegaard Heisel, Freja Drost Andersen, Sâmia Joca, Lambert Kristiansen Sørensen, Ulf Simonsen, Jørgen Bo Hasselstrøm, Charlotte Uggerhøj Andersen, Kirstine Lykke Nielsen
Changes in pharmacokinetics and endogenous metabolites may underlie additive biological effects of concomitant use of antipsychotics and opioids. In this study, we employed untargeted metabolomics analysis and targeted analysis to examine the changes in drug metabolites and endogenous metabolites in the prefrontal cortex (PFC), midbrain, and blood of rats following acute co-administration of quetiapine and methadone. Rats were divided into four groups and received cumulative increasing doses of quetiapine (QTP), methadone (MTD), quetiapine + methadone (QTP + MTD), or vehicle (control)...
October 23, 2023: Archives of Toxicology
https://read.qxmd.com/read/37864676/evidence-based-recommendations-for-the-pharmacological-treatment-of-women-with-schizophrenia-spectrum-disorders
#37
REVIEW
Bodyl A Brand, Elske J M Willemse, Iris M H Hamers, Iris E Sommer
PURPOSE OF REVIEW: Despite clear evidence that sex differences largely impact the efficacy and tolerability of antipsychotic medication, current treatment guidelines for schizophrenia spectrum disorders (SSD) do not differentiate between men and women. This review summarizes the available evidence on strategies that may improve pharmacotherapy for women and provides evidence-based recommendations to optimize treatment for women with schizophrenia. RECENT FINDINGS: We systematically searched PubMed and Embase for peer-reviewed studies on three topics: (1) sex differences in dose-adjusted antipsychotic serum concentrations, (2) hormonal augmentation therapy with estrogen and estrogen-like compounds to improve symptom severity, and (3) strategies to reduce antipsychotic-induced hyperprolactinemia...
November 2023: Current Psychiatry Reports
https://read.qxmd.com/read/37833613/effects-of-the-antipsychotic-quetiapine-on-sleep-and-breathing-a-review-of-clinical-findings-and-potential-mechanisms
#38
REVIEW
Cricket Fauska, Tarun Bastiampillai, Robert J Adams, Gary Wittert, Danny J Eckert, Kelly A Loffler
Quetiapine is an antipsychotic medication indicated for schizophrenia and bipolar disorder. However, quetiapine also has hypnotic properties and as such is increasingly being prescribed at low doses 'off-label' in people with insomnia symptoms. Pharmacologically, in addition to its dopaminergic properties, quetiapine also modulates multiple other transmitter systems involved in sleep/wake modulation and potentially breathing. However, very little is known about the impact of quetiapine on obstructive sleep apnoea (OSA), OSA endotypes including chemosensitivity, and control of breathing...
October 13, 2023: Journal of Sleep Research
https://read.qxmd.com/read/37812512/treatment-of-severe-tardive-dyskinesia-with-concurrent-administration-of-olanzapine-clonazepam-baclofen-and-gabapentin-a-case-report
#39
JOURNAL ARTICLE
Xiaoling Guo, Jiong Chen, Weixin Wang, Bo Jiang, Bo Liang
BACKGROUND: Long-term use of antipsychotics or other dopamine antagonists can result in the extrapyramidal side effect of tardive dyskinesia (TD).Case presentation: An 18-year-old female patient experienced abnormal speech and behavior and because of an equivocal diagnosis, she was given daily doses of 300 mg of quetiapine and 60 mg of ziprasidone. She had used these medications for 2 years before the appearance of involuntary abnormal movements. These movements, which were classified as TD, steadily worsened and markedly interfered with her daily life...
October 2023: Journal of International Medical Research
https://read.qxmd.com/read/37801962/pneumomediastinum-a-case-report-of-baclofen-toxicity
#40
Fatemeh Zari Meidani, Rahem Rahmati, Mojdeh Ghorbankhani, Vahid Reisi-Vanani, Babak Alavi Farzaneh
INTRODUCTION: Baclofen is a γ -aminobutyric acid (GABA) agonist used to treat spasticity; however, it may be toxic at dosages above 200 mg. The psychological, nervous, cardiovascular, gastrointestinal, musculoskeletal, and respiratory systems are all affected. This report represents a case with the rare respiratory complications brought on by baclofen toxicity: atelectasis and pneumomediastinum. PRESENTATION OF CASE: A 19-year-old female was admitted to the emergency department after attempting suicide by taking 20 baclofen tablets (500 mg)...
October 2023: International Journal of Surgery Case Reports
keyword
keyword
86415
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.